Advances in Renal Cell Carcinoma Diagnosis: A Review on Biomarkers
A precise diagnosis integrating histopathology, IHC, and molecular testing is critical for guiding management, identifying hereditary syndromes, and implementing personalized tumor biology-based therapies. With evolving molecular diagnostic and circulating biomarkers, careful clinical integration is needed to optimize outcomes and treatment.
Authors
- Nuno Tiago Tavares
- João Lobo
- Costantino Ricci
- Fernanda Fernandes-Pontes
- Rui Henrique
- Ângelo Rodrigues
- Agnese Orsatti
- João Ricardo e Silva
- Carmen Jerónimo
Publication Details
- Journal
- Pathobiology
- Published
- 2026-01-27
- DOI
- https://doi.org/10.1159/000550723
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00